Wegovy Prices in the UK: the Honest Picture

The myth: a low monthly price means an affordable treatment

The most common misconception about Wegovy prices is that the cheapest monthly figure represents the cheapest overall cost. It rarely does. Many providers quote the cost of the pen alone, then charge separately for the initial consultation, the prescription, follow-up dose reviews and delivery. Stack those extras together and a headline price that looked lean can turn out to be considerably more than a competitor's all-in figure. Before accepting any quote, it takes under a minute to check whether the pharmacy is on the GPhC register, search by name or registration number and look for a live, current listing.

Prices across the UK private market are also genuinely uneven. Eli Lilly raised Mounjaro's UK list price significantly from September 2025, and the private market for Wegovy has followed a similar upward pattern as demand has grown. Reported private prices range roughly £149–£300 or more per month depending on dose and provider, with higher doses typically priced higher. Any figure below that range from an unverified source deserves scrutiny, not celebration. The full Wegovy price list breakdown covers how those dose-by-dose figures are structured.

What drives Wegovy prices up as your dose increases

Wegovy is titrated from 0.25mg up through 0.5mg, 1mg, 1.7mg and 2.4mg, stepped up roughly every four weeks by the prescriber as your body adjusts. The MHRA also approved a higher 7.2mg maintenance dose in early 2026, with a dedicated single-dose pen confirmed in April 2026, see the GOV.UK announcement for the detail. Each step up in dose typically corresponds to a step up in price, which is why the price at each dose stage is worth knowing before you start, not after.

Clinical trials support this titration approach: STEP 1, published in the New England Journal of Medicine, found semaglutide 2.4mg produced around 15% average weight reduction over 68 weeks alongside lifestyle changes. The MHRA-approved 7.2mg dose extended the ceiling further, with trials reporting approximately 20.7% average weight loss at that level. Those figures come from clinical-trial populations and individual results vary; a prescriber looks at your health picture, not a population average. What this means practically: your monthly cost will likely rise as you titrate up, and a provider's pricing structure at higher doses is worth checking before you commit.

The relationship between weight loss and Wegovy pricing is something our prescribers are asked about regularly, it is a fair question, and the short answer is that the two are related through dose, not directly.

What nume's price actually includes, and why we're not the cheapest

nume is a GPhC-registered online pharmacy (premises registration 9012878) sourcing Wegovy through the licensed UK supply chain. Our pricing is transparent and all-in: consultation, prescription, treatment and next-working-day DPD delivery are covered in a single figure. There are no subscriptions and no auto-renewals. Every repeat order is clinically re-reviewed by a prescriber before anything is dispatched.

We are not the cheapest option available. That is a deliberate choice. A named prescriber reviews every consultation the same day, not a chatbot, not an automated eligibility screen. ID and live weight are verified before approval. If something in your history warrants a conversation, it gets one. That level of clinical infrastructure costs money, and we think that cost is justified for a prescription medicine. The cheapest listing for a Prescription-Only Medicine is not a bargain; it is a question worth asking. What did they cut to get there?

For context on what different pen formats cost, Wegovy pen prices are explained separately. If you are already mid-treatment and considering switching provider, new Wegovy prices for transfer patients covers what to bring to a consultation.

Why 'cheapest' is the wrong test for a prescription medicine

The MHRA has issued clear public warnings about counterfeit weight-loss pens sold online, some containing insulin rather than semaglutide, leading to hospitalisations. Enforcement in 2025 resulted in the seizure of around 20 million doses of illegally traded weight-loss medicines (roughly £45m street value). The pattern in every case: prices well below market, sellers operating without a verifiable pharmacy registration, no genuine clinical assessment involved. See the MHRA's Yellow Card portal to report any suspect seller.

A legitimate private prescription for Wegovy in the UK requires a real prescriber and a real pharmacy. The consultation protects you as much as it protects the system, a prescriber reviewing your full medical picture before supply is not bureaucracy, it is medicine working as intended. Price is one factor. Whether the supply is genuine, properly stored, and clinically supervised is the factor that actually keeps you safe.

Ready to get a clear picture of your options? Speak to our prescribers, the consultation is free, same-day, and tells you exactly where you stand.